X-47846275-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_007137.5(ZNF81):c.8C>T(p.Ala3Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0161 in 1,207,460 control chromosomes in the GnomAD database, including 136 homozygotes. There are 6,115 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_007137.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF81 | NM_007137.5 | c.8C>T | p.Ala3Val | missense_variant | 2/5 | ENST00000338637.13 | NP_009068.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF81 | ENST00000338637.13 | c.8C>T | p.Ala3Val | missense_variant | 2/5 | 3 | NM_007137.5 | ENSP00000341151 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0117 AC: 1313AN: 112290Hom.: 14 Cov.: 23 AF XY: 0.00999 AC XY: 344AN XY: 34440
GnomAD3 exomes AF: 0.00925 AC: 1607AN: 173816Hom.: 5 AF XY: 0.00854 AC XY: 519AN XY: 60784
GnomAD4 exome AF: 0.0166 AC: 18178AN: 1095118Hom.: 123 Cov.: 30 AF XY: 0.0160 AC XY: 5771AN XY: 361160
GnomAD4 genome AF: 0.0117 AC: 1309AN: 112342Hom.: 13 Cov.: 23 AF XY: 0.00997 AC XY: 344AN XY: 34502
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 27, 2012 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
History of neurodevelopmental disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2012 | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at